Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Drugs and Targets: Blincyto granted accelerated approval in R/R ALL
This article is from
The Cancer Letter
archive.
Vol. 40 No. 45 | December 5, 2014
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
AACR Honorary Memberships; ASCO Awards
July 20, 1990
TCL Archive
Funding Opportunities
November 15, 2002
TCL Archive
Possible Breach of Patient Confidentially By Calif. Physician; NCI
May 6, 1994
TCL Archive
NeoPharm To Begin Phase III Trial For Glioblastoma
December 26, 2003
TCL Archive
House Passes Cancer Bill With Mandates for NCI
September 28, 2012
TCL Archive
OMB Reprogramming Ban Criticized
September 20, 1985
